WO1990000200A1 - Thermal release of recombinant protein into culture media - Google Patents

Thermal release of recombinant protein into culture media Download PDF

Info

Publication number
WO1990000200A1
WO1990000200A1 PCT/US1989/001917 US8901917W WO9000200A1 WO 1990000200 A1 WO1990000200 A1 WO 1990000200A1 US 8901917 W US8901917 W US 8901917W WO 9000200 A1 WO9000200 A1 WO 9000200A1
Authority
WO
WIPO (PCT)
Prior art keywords
protein
host
nutrient medium
aqueous nutrient
substantially pure
Prior art date
Application number
PCT/US1989/001917
Other languages
French (fr)
Inventor
Malcolm A. J. Finkelman
Timothy Kwok-Tim Lee
Original Assignee
Genex Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genex Corporation filed Critical Genex Corporation
Publication of WO1990000200A1 publication Critical patent/WO1990000200A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • C12N1/066Lysis of microorganisms by physical methods
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Definitions

  • the invention relates to methods for the isolation of substantially pure polypeptides from recombinant micro ⁇ organisms.
  • Proteins produced by host cells are normally trapped within the cells or secreted into the surrounding growth medium. In the former case, the cells must be ruptured to permit the desired protein to be isolated, whereas in the latter case, it can be separated from the growth media. Even in the case of secreted proteins, the preparation from which the protein is to be isolated is relatively complex, contain ⁇ ing a variety of other substances. Despite efficient separa ⁇ tion techniques, both the purity and the yield of the desired protein may be low. Lofdahl, S., et al ., PCT application, publication no. WO 84/03103, published 16 August 1984.
  • Lofdahl et al .. supra have developed methods for selectively isolating a desired protein or polypeptide by constructing a recombinant vector containing a DNA sequence coding for the desired protein or polypeptide which is operatively linked to a DNA sequence coding for protein A.
  • the expressed fusion protein is then selectively isolated by absorbing onto an IgG-supporting carrier, which binds protein A, followed by desorpt on of the fusion protein.
  • the fusion protein is then cleaved at a unique cleavage site with a cleavage agent, which may include proteases, hydroxylamine, cyanogen bromide or formic acid, to give the purified protein.
  • a cleavage agent which may include proteases, hydroxylamine, cyanogen bromide or formic acid
  • the invention relates to a method for the isolation of a substantially pure polypeptide expressed by a recombinant host comprising:
  • Figure 1 depicts a densitometric scan of a whole cell E coli extract of protein G separated by polyacrylamide electro- phoresis.
  • Figure 2 depicts a densitometric scan of the supernatant separated by polyacrylamide electrophoresis after heating an aqueous nutrient medium containing E. coli transformed with a vector containing a gene encoding protein G to 80 ⁇ C for 5 minutes.
  • the major peak is protein G.
  • the invention is directed toward a method for the isolation of substantially pure polypeptide from a recombinant bacterial host by culturing the host under protein-producing conditions, heating the aqueous nutrient medium to 50-100"C for a time not to exceed 1 hour, and isolating the substan ⁇ tially pure polypeptide so produced. Although longer heating times and higher temperatures may be utilized, they are not preferred since degradation of the protein occurs under these harsher conditions.
  • Preferred bacterial hosts include Gram-negative organ ⁇ isms, in particular, E. coli, Erwin a sp. and Klebsiella sp. The most preferred host is E. coli.
  • the aqueous nutrient medium is heated to 50- 100"C for about 5 minutes. Most preferably, the aqueous nutrient medium is heated to about 80°C for about 5 minutes. Under the most preferable conditions, substantially pure polypeptide is released into the culture media free from significant degradation.
  • the method has the added advantage that endogenous proteases are inactivated by the high tempera ⁇ tures of the method, thus preventing proteolysis of the polypeptide.
  • polypeptide is intended protein G or protein G variants having the i munoglobulin binding proper- ties of protein G, protein A or protein A variants having the immunoglobulin binding properties of protein A, and those polypeptides which may be produced in substantially pure form by the method of the invention, which include any peptide which does not irreversibly denature at 50-100 c C and which can penetrate the cell wall during the heating procedure.
  • proteins may include, but are not limited to, small proteins such as hormones, e.g., parathyroid hormone, growth hormone, ganadotropins (FSH, luteinizing hormone, chorionogonado- tropin), insulin, ACTH, prolactin, placenta! lactogen, melanocyte stimulating hormone, thyrotropin, calcitonin, enkephalin, angiotensin, and small cytokines.
  • hormones e.g., parathyroid hormone, growth hormone, ganadotropins (FSH, luteinizing hormone, chorion
  • the recombinant microorganism contains a vector containing the gene which encodes protein G.
  • Vectors which contain the genes which encode protein G and protein G variants which have the immunoglobulin binding properties of protein G are described, for example, in International Application PCT/US87/00329, co-pending U.S. Application Serial No. 063,959, filed June 19, 1987, and co- pending U.S. Application Serial No. 209,236, filed June 20, 1988, the disclosures of which are incorporated by reference herein in their entirety.
  • the vectors may incorporate promoters derived from, for example, bacteriophage, especially bacteriophage lambda, the E. coli tryptophan operon, the ______ coli lac operon, the E.
  • coli J-glucuronidase locus etc.
  • Suitable recombinant hosts include E. coli GX7820, J . coli GX7823, E. coli GX8464, and E. coli GX8465.
  • the production organism is the transformed host _____ coli GX1201 or E. coli GX6705, which contains the vector pGX5204 or a degenerate variant thereof.
  • polypeptides which are substantially one major band by SDS-PAGE polyacryla- mide electrophoresis and which contain only minor amounts of other proteins which normally contaminate a whole cell lysate, as evidenced by the presence of other minor bands.
  • the recombinant cells may be cultivated under any physiologically compatible conditions of pH and temperature, in any suitable nutrient medium containing assimilable sources of carbon, nitrogen and essential minerals that support cell growth.
  • Recombinant protein-producing cultivation conditions will vary according to the type of vector used to transform the host cells.
  • certain expression vectors comprise regulatory regions which require cell growth at certain temperatures, or addition of certain chemicals to the cell growth medium, to initiate the gene expression which results in the production of the recombinant polypeptide.
  • the term recombinant "protein-producing conditions,” as used herein, is not meant to be limited to any one set of cultivation conditions.
  • the expressed protein may be recovered from the fermenta ⁇ tion broth using any of the methods commonly known to those skilled in the art.
  • dead cells and insoluble debris are removed from the aqueous nutrient medium by filtration or centrifugation.
  • Protein G or other recombinant protein may then be purified from the fermentation media using standard procedures such as absorption to immobilized immuno ⁇ globulin, as described by Sjoquist, U.S. Patent No. 3,850,798 (1974), ion exchange or gel chromatography, precipitation (e.g., with ammonium sulfate), dialysis, filtration or a combination of these methods.
  • the method of the invention is not limited to expression of polypeptides which have leader sequences.
  • the invention does not depend on induction of filamentous growth of E. coli as described by Abrahamsen et al .. European Patent Application 0225860. Cell death is complete upon heating at 70-80°C; thus, induction of filamentous growth at these temperatures is not possible.
  • the fermenta ⁇ tion media is heated to 50-100°C in as little time as 5 minutes, there is little time for meaningful physiologically related morphological changes.
  • Soluble polypeptide for example protein G
  • Soluble polypeptide diffuses through the PG layer without significant impediment, by a dialysis-like mechanism.
  • the polypeptides which may be recovered according to the invention, as listed above, are those which remain soluble and do not denaturate upon heating.
  • Recombinant E. coli containing a vector which encodes a protein G variant having the immunoglobulin binding properties of protein G was cultivated in an aqueous nutrient medium (see Table 1) at 32 ⁇ C, 800 rpm, 1 vvm, pH 7.2 ⁇ 0.1 (titrants: 10% NaOH, 2M H3PO4). After cultivation at 32°C for 6-12 hours, expression of recombinant protein G was induced by raising the broth temperature to 42 ⁇ C for 1 hr. After 1 hr at 42°C, the broth temperature was reduced to 39 ⁇ C and maintained at that temperature for 3 hours.
  • heating at 80°C results in the release of substan ⁇ tially all of the protein G into the supernatant and retention of other proteins within the cells.
  • Example 1 The experiment in Example 1 was repeated using a 70°C heat treatment instead of an 80°C heat treatment to induce release of protein G. At this temperature, the release of protein G into the broth does not appear to be complete. Although substantially pure, the protein G appears to degrade after extended heating at 70°C as evidenced by fuzzy bands on the polyacrylamide electrophoresis gel.
  • Example 1 was repeated, except that the holding period at 80 ⁇ C was reduced to about 5 minutes. This brief exposure resulted in essentially quantitative release of substantially pure protein G as observed by SDS PAGE electrophoresis ( Figure 2). In addition, the apparent degradation of protein G due to prolonged heating (as evidenced by the widening of the protein G band on the gel) was greatly reduced.
  • Recombinant E. coli containing a vector which encodes Protein A strain NRRL 15910 (U.S. Patent No. 4,691,009) was cultivated in an aqueous medium (see Table 2) at 37°C, 800 rpm, 100 min., pH 7.2 ⁇ 0.1 (titrants: 10% NH 4 0H, 2 M H 3 P0 ). After growth leveled off, the broth was heated to 80 ⁇ C for 5 min, then cooled to 30 ⁇ C. SDS-PAGE analysis of the distribu ⁇ tion of recombinant Protein A demonstrated that prior to heating, the Protein A was present in the cells and very little was detectable in the supernatant.

Abstract

The invention relates to a method for the isolation of a substantially pure polypeptide from a recombinant bacterial host by culturing the host under recombinant protein-producing conditions followed by heating the aqueous nutrient medium to 50-100°C for a time not to exceed 1 hour and recovering the substantially pure polypeptide so produced.

Description

TITLE OF THE INVENTION
Thermal release of recombinant protein into culture media.
FIELD OF THE INVENTION
The invention relates to methods for the isolation of substantially pure polypeptides from recombinant micro¬ organisms.
BACKGROUND OF THE INVENTION
The use of bacteria to express foreign genes has' faced many practical and biological problems, including the instabi¬ lity of the polypeptide due to proteolysis, low levels of expression, and precipitation of the protein product. Precipitation is correlated to misfolding and lack of biologi¬ cal activity of the protein after purification. To solve these problems, a variety of techniques have been developed to enhance the expression of gene products by transformed hosts. These methods include the use of various promoters to allow the regulation of the level of expression, gene fusions to stabilize normally unstable proteins in the cell, and the use of signal peptides to translocate proteins out of the cyto¬ plasm to the periplasmic space. For example, Abrahamsen, L., et al . , European Patent Application Publication No. 0 225860, published June 16, 1987, discloses methods for the isolation of expressed gene products having signal sequences from E. coli by induction of filamentous growth, where the expression of the desired gene product is dependent on the heat shock response. This response results in a quantitative leakage of periplasmic located proteins to the growth medium at tempera¬ tures of 30-42'C. Using these conditions, high expression and export of protein A was reported. However, this method is useful only for genes encoding signal sequences fused to protein A. Therefore, it is not widely applicable to all genes.
Proteins produced by host cells are normally trapped within the cells or secreted into the surrounding growth medium. In the former case, the cells must be ruptured to permit the desired protein to be isolated, whereas in the latter case, it can be separated from the growth media. Even in the case of secreted proteins, the preparation from which the protein is to be isolated is relatively complex, contain¬ ing a variety of other substances. Despite efficient separa¬ tion techniques, both the purity and the yield of the desired protein may be low. Lofdahl, S., et al ., PCT application, publication no. WO 84/03103, published 16 August 1984.
Lofdahl et al .. supra, have developed methods for selectively isolating a desired protein or polypeptide by constructing a recombinant vector containing a DNA sequence coding for the desired protein or polypeptide which is operatively linked to a DNA sequence coding for protein A. The expressed fusion protein is then selectively isolated by absorbing onto an IgG-supporting carrier, which binds protein A, followed by desorpt on of the fusion protein. The fusion protein is then cleaved at a unique cleavage site with a cleavage agent, which may include proteases, hydroxylamine, cyanogen bromide or formic acid, to give the purified protein. Despite the above-described methods for isolating polypeptides produced by recombinant means, a need continues to exist for methods which allow the selective production of substantially pure polypeptides.
SUMMARY OF THE INVENTION
The invention relates to a method for the isolation of a substantially pure polypeptide expressed by a recombinant host comprising:
(a) cultivating on an aqueous nutrient medium, under recombinant protein producing conditions, a micro¬ organism transformed by a vector comprising a DNA sequence encoding said polypeptide, said vector further comprising expression signals which are recognized by said host and which direct the expression of said DNA sequence;
(b) heating said aqueous nutrient medium to 50- 100°C for a time not to exceed one hour to cause release of substantially pure polypeptide from the host; and
(c) recovering said substantially pure polypeptide from the aqueous nutrient medium.
Unexpectedly, it has been discovered that when a recom¬ binant host is heated to 50-100cC for a time not to exceed 1 hour, high levels of substantially pure polypeptide are released into the growth media. This method does not rely on filamentous growth of the host as taught by Abrahamsen et al . , supra, and in fact results in almost immediate and complete cell death at 70-80°C.
DESCRIPTION OF THE FIGURES
Figure 1 depicts a densitometric scan of a whole cell E coli extract of protein G separated by polyacrylamide electro- phoresis.
Figure 2 depicts a densitometric scan of the supernatant separated by polyacrylamide electrophoresis after heating an aqueous nutrient medium containing E. coli transformed with a vector containing a gene encoding protein G to 80βC for 5 minutes. The major peak is protein G.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
The invention is directed toward a method for the isolation of substantially pure polypeptide from a recombinant bacterial host by culturing the host under protein-producing conditions, heating the aqueous nutrient medium to 50-100"C for a time not to exceed 1 hour, and isolating the substan¬ tially pure polypeptide so produced. Although longer heating times and higher temperatures may be utilized, they are not preferred since degradation of the protein occurs under these harsher conditions.
Preferred bacterial hosts include Gram-negative organ¬ isms, in particular, E. coli, Erwin a sp. and Klebsiella sp. The most preferred host is E. coli.
Preferably, the aqueous nutrient medium is heated to 50- 100"C for about 5 minutes. Most preferably, the aqueous nutrient medium is heated to about 80°C for about 5 minutes. Under the most preferable conditions, substantially pure polypeptide is released into the culture media free from significant degradation. The method has the added advantage that endogenous proteases are inactivated by the high tempera¬ tures of the method, thus preventing proteolysis of the polypeptide.
By the term "polypeptide" is intended protein G or protein G variants having the i munoglobulin binding proper- ties of protein G, protein A or protein A variants having the immunoglobulin binding properties of protein A, and those polypeptides which may be produced in substantially pure form by the method of the invention, which include any peptide which does not irreversibly denature at 50-100cC and which can penetrate the cell wall during the heating procedure. Such proteins may include, but are not limited to, small proteins such as hormones, e.g., parathyroid hormone, growth hormone, ganadotropins (FSH, luteinizing hormone, chorionogonado- tropin), insulin, ACTH, prolactin, placenta! lactogen, melanocyte stimulating hormone, thyrotropin, calcitonin, enkephalin, angiotensin, and small cytokines.
In a preferred embodiment, the recombinant microorganism contains a vector containing the gene which encodes protein G. Vectors which contain the genes which encode protein G and protein G variants which have the immunoglobulin binding properties of protein G are described, for example, in International Application PCT/US87/00329, co-pending U.S. Application Serial No. 063,959, filed June 19, 1987, and co- pending U.S. Application Serial No. 209,236, filed June 20, 1988, the disclosures of which are incorporated by reference herein in their entirety. The vectors may incorporate promoters derived from, for example, bacteriophage, especially bacteriophage lambda, the E. coli tryptophan operon, the ______ coli lac operon, the E. coli J-glucuronidase locus, etc. Suitable recombinant hosts, disclosed in copending U.S. Application Serial No. 063,959, include E. coli GX7820, J . coli GX7823, E. coli GX8464, and E. coli GX8465. Most preferably, the production organism is the transformed host _____ coli GX1201 or E. coli GX6705, which contains the vector pGX5204 or a degenerate variant thereof.
By the method of this invention, high levels of substan¬ tially pure polypeptides can be obtained under conditions where they may be easily isolated from the fermentation broth. By the term "substantially pure" is intended polypeptides which are substantially one major band by SDS-PAGE polyacryla- mide electrophoresis and which contain only minor amounts of other proteins which normally contaminate a whole cell lysate, as evidenced by the presence of other minor bands.
The recombinant cells may be cultivated under any physiologically compatible conditions of pH and temperature, in any suitable nutrient medium containing assimilable sources of carbon, nitrogen and essential minerals that support cell growth. Recombinant protein-producing cultivation conditions will vary according to the type of vector used to transform the host cells. For example, certain expression vectors comprise regulatory regions which require cell growth at certain temperatures, or addition of certain chemicals to the cell growth medium, to initiate the gene expression which results in the production of the recombinant polypeptide. Thus, the term recombinant "protein-producing conditions," as used herein, is not meant to be limited to any one set of cultivation conditions.
The expressed protein may be recovered from the fermenta¬ tion broth using any of the methods commonly known to those skilled in the art. As a first step, dead cells and insoluble debris are removed from the aqueous nutrient medium by filtration or centrifugation. Protein G or other recombinant protein may then be purified from the fermentation media using standard procedures such as absorption to immobilized immuno¬ globulin, as described by Sjoquist, U.S. Patent No. 3,850,798 (1974), ion exchange or gel chromatography, precipitation (e.g., with ammonium sulfate), dialysis, filtration or a combination of these methods.
The method of the invention is not limited to expression of polypeptides which have leader sequences. In addition, the invention does not depend on induction of filamentous growth of E. coli as described by Abrahamsen et al .. European Patent Application 0225860. Cell death is complete upon heating at 70-80°C; thus, induction of filamentous growth at these temperatures is not possible. Moreover, since the fermenta¬ tion media is heated to 50-100°C in as little time as 5 minutes, there is little time for meaningful physiologically related morphological changes.
Although the inventors do not wish to be bound by any particular theory, it is hypothesized that the surprising level of purity of the expressed gene products, which results from heating at 50-100cC, is due to a dialysis-like effect. Such an effect might be expected if the heat treatment causes complete loss of membrane integrity. As the temperatures utilized in the practice of the invention likely cause the complete destruction of the cytoplasmic and outer cell membranes, the only remaining barrier to the release of the cell contents would be the peptidoglycan (PG) layer of the cell envelope. The protoplasmic contents are likely trapped within the PG barrier as a result of heat denaturation and coagulation. This theory is supported by the observation of condensed, granular cytoplasmic material by microscopic inspection after heat treatment. Soluble polypeptide, for example protein G, diffuses through the PG layer without significant impediment, by a dialysis-like mechanism. Thus, the polypeptides which may be recovered according to the invention, as listed above, are those which remain soluble and do not denaturate upon heating.
The following examples are provided to illustrate the invention, and are not to be construed as limiting the invention in any manner. EXAMPLE 1 Preparation of Substantially Pure Protein G
Recombinant E. coli containing a vector which encodes a protein G variant having the immunoglobulin binding properties of protein G (GX8465, see U.S. Application Serial No. 063,959, filed June 19, 1987, incorporated by reference herein) was cultivated in an aqueous nutrient medium (see Table 1) at 32βC, 800 rpm, 1 vvm, pH 7.2 ± 0.1 (titrants: 10% NaOH, 2M H3PO4). After cultivation at 32°C for 6-12 hours, expression of recombinant protein G was induced by raising the broth temperature to 42βC for 1 hr. After 1 hr at 42°C, the broth temperature was reduced to 39βC and maintained at that temperature for 3 hours. As shown in Figure 1, separation of a whole cell extract by SDS-PAGE electrophoresis followed by densitometric scanning of the gel shows that the extract is substantially contaminated by other proteins. The broth was then heated to 80βC and maintained at that temperature for one hour. Samples were removed periodically for analysis by gel electrophoresis (SDS-PAGE). Both cell pellets and cell free media were analyzed at 0, 15, 30 and 60 minutes after heating to 80βC.
Before heating, the pellet contained substantially impure protein G. At this time, no protein G was detected in the fermentation media. At time = 0 (when the temperature reached 80°C), a considerable band of substantially pure protein G was found in the cell-free medium. The corresponding cell pellet showed reduced levels of protein G. At time = 15, only a trace of protein G remained within the pellet. After 30 minutes, no protein G was detectable in the pellet. In contrast, after heating for 15 minutes at 80°C, substantially pure protein G was observed in the supernatant. The relative purity of the protein G in the supernatant did not substan- tially decline after continued heating at 80°C for one hour. However, some chemical alteration, as evidenced by a fuzziness of the protein G band, was observed after 30 in. at 80°C.
Thus, heating at 80°C results in the release of substan¬ tially all of the protein G into the supernatant and retention of other proteins within the cells.
TABLE 1 Fermentation Media Composition
Ingredients Concentration
Acid digest casein 30 g/1
* Glucose 30 g/1 K2HP04 5 g/1 (NH4)2S04 3 g/1 MgS04.7H20 0.25 g/1 CaCl2.2H20 0.1 g/1 M44 salts (100 X) 10 ml/1
* Biotin 0.1 mg/1
* Nicotinamide 1.0 mg/1
* Ampicillin 100 mg/1 Distilled H 0 dilute to 1360 ml SAG 4130 0.25 ml/1
* = post autoclaving additions
EXAMPLE 2 Release of Protein G at 70°C
The experiment in Example 1 was repeated using a 70°C heat treatment instead of an 80°C heat treatment to induce release of protein G. At this temperature, the release of protein G into the broth does not appear to be complete. Although substantially pure, the protein G appears to degrade after extended heating at 70°C as evidenced by fuzzy bands on the polyacrylamide electrophoresis gel.
EXAMPLE 3 Release of Protein G at 80βC for 5 Minutes
Example 1 was repeated, except that the holding period at 80βC was reduced to about 5 minutes. This brief exposure resulted in essentially quantitative release of substantially pure protein G as observed by SDS PAGE electrophoresis (Figure 2). In addition, the apparent degradation of protein G due to prolonged heating (as evidenced by the widening of the protein G band on the gel) was greatly reduced.
EXAMPLE 4 Preparation of Substantially Pure Protein A
Recombinant E. coli containing a vector which encodes Protein A, strain NRRL 15910 (U.S. Patent No. 4,691,009) was cultivated in an aqueous medium (see Table 2) at 37°C, 800 rpm, 100 min., pH 7.2 ± 0.1 (titrants: 10% NH40H, 2 M H3P0 ). After growth leveled off, the broth was heated to 80βC for 5 min, then cooled to 30βC. SDS-PAGE analysis of the distribu¬ tion of recombinant Protein A demonstrated that prior to heating, the Protein A was present in the cells and very little was detectable in the supernatant. After heating to 80°C, substantially all of the Protein A was released from the cells was present in the broth supernatant in substantially pure form. Thus, heat inactivation at 80βC results in the release of substantially all of the Protein A into the super¬ natant and the retention of other proteins within the cells in a manner analogous to Protein G. TABLE 2 Fermentation Media Composition
Ingredients
Tryptone
Yeast extract
K2HP04
(NH4)2S04
MgS04.7H20
CaCl2.2H20
M-44 salts (100 X)
Figure imgf000013_0001
Having now fully described this invention, it will be understood by those of skill in the art that the same can be performed within a wide and equivalent range of conditions, formulations and other parameters without affecting the scope of the invention or any embodiment thereof.

Claims

WHAT IS CLAIMED IS:
1. A method for the isolation of a substantially pure polypeptide expressed by a recombinant host comprising:
(a) cultivating on an aqueous nutrient medium, under recombinant protein producing conditions, a host transformed by a vector containing a DNA sequence encoding a polypeptide, said vector further comprising expression signals which are recognized by said host and which direct the expression of said DNA sequence;
(b) heating said aqueous nutrient medium to 50- 100βC for a time not to exceed 1 hour to cause release of substantially pure polypeptide from the host; and
(c) recovering said substantially pure polypeptide from the aqueous nutrient medium.
2. The method of claim 1, wherein said recovering comprises removal of dead cells and insoluble debris from said aqueous nutrient medium.
3. The method of claim 1, wherein said host is a Gram- negative bacterium.
4. The method of claim 1, wherein said host is selected from the group consisting of E. coli, Erwinia sp. and Kleb- siella sp.
5. The method of claim 1, wherein said host is E. coli.
6. The method of claim 1, wherein said polypeptide is selected from the group consisting of protein G or a variant thereof having the immunoglobulin-binding properties of protein G, or protein A or a variant thereof having the immunoglobulin-binding properties of protein A.
7. The method of claim 1, wherein said vector contains a DNA sequence which encodes protein G or a variant thereof having the immunoglobulin-binding properties of protein G.
8. The method of claim 7, wherein said vector is pGX5204.
9. The method of claim 1, wherein said host is E. coli strain NRRL 15910 which contains a vector which encodes protein A.
10. The method of claim 1, wherein said aqueous nutrient medium is heated to 80°C for about 5 minutes to cause release of substantially pure polypeptide from the host.
11. A method for the isolation of of a substantially pure protein G, or a variant thereof having the immunoglobulin binding properties of protein G, expressed by a recombinant host comprising:
(a) cultivating on an aqueous nutrient medium, under recombinant protein G producing conditions, a host transformed by a vector containing a DNA sequence encoding protein G, said vector further comprising expression signals which are recognized by said host and which direct the expression of said DNA sequence;
(b) heating said aqueous nutrient medium to 50- 100°C for a time not to exceed 1 hour to cause release of substantially pure protein G from the host; and
(c) recovering said substantially pure protein G from the aqueous nutrient medium.
12. The method of claim 9, wherein said host is E. coli.
13. The method of claim 9, wherein said vector is pGX5204.
14. A method for the isolation of a substantially pure protein G variant, having the immunoglobulin binding proper¬ ties of protein G, expressed by recombinant E. coli which comprises:
(a) cultivating on an aqueous nutrient medium, under recombinant protein G producing conditions, E. coli transformed by the vector pGX5204;
(b) heating the aqueous nutrient medium to 50-100βC for a time not to exeed 1 hour to cause release of substan¬ tially pure protein G from said E. coli; and
(c) recovering said substantially pure protein G variant from the aqueous nutrient medium.
15. A method for the isolation of a substantially pure protein G variant having the immunoglobulin-binding binding properties of protein G, expressed from recombinant E. coli which comprises:
(a) cultivating on an aqueous nutrient medium, under recombinant protein G producing conditions, E. coli transformed by the vector pGX5204;
(b) heating the aqueous nutrient medium to about 80°C for about 5 minutes to cause release of said substantial¬ ly pure protein G; variant and
(c) recovering said substantially pure protein G variant from the aqueous nutrient medium.
PCT/US1989/001917 1988-06-27 1989-05-05 Thermal release of recombinant protein into culture media WO1990000200A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21190488A 1988-06-27 1988-06-27
US211,904 1988-06-27

Publications (1)

Publication Number Publication Date
WO1990000200A1 true WO1990000200A1 (en) 1990-01-11

Family

ID=22788768

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1989/001917 WO1990000200A1 (en) 1988-06-27 1989-05-05 Thermal release of recombinant protein into culture media

Country Status (3)

Country Link
EP (1) EP0422124A4 (en)
JP (1) JPH03505401A (en)
WO (1) WO1990000200A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600247A2 (en) * 1992-11-05 1994-06-08 Hoechst Aktiengesellschaft Method of selective desactivation of unwanted protein in a protein mixture, with a mircowave radiation
US5985304A (en) * 1998-02-25 1999-11-16 Battelle Memorial Institute Barrier preventing wood pest access to wooden structures
US6596509B1 (en) 1998-07-10 2003-07-22 Cornell Research Foundation, Inc. Recombinant constructs and systems for secretion of proteins via type III secretion systems
WO2004048588A1 (en) * 2002-11-26 2004-06-10 Novo Nordisk A/S Process for purifying a fermentation-derived product
WO2006101441A2 (en) * 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8114959B2 (en) 2003-06-03 2012-02-14 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
US8114833B2 (en) 2003-11-20 2012-02-14 Novo Nordisk A/S Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
US8614181B2 (en) 2003-06-03 2013-12-24 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
US8710181B2 (en) 2004-08-31 2014-04-29 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
US8748376B2 (en) 2004-11-12 2014-06-10 Novo Nordisk A/S Stable formulations of peptides
US8846618B2 (en) 2001-06-28 2014-09-30 Novo Nordisk A/S Stable formulation of modified GLP-1
RU2646103C2 (en) * 2016-03-30 2018-03-01 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Method for renatured protein g isolation from marked polyacrylamide gel
US11318191B2 (en) 2020-02-18 2022-05-03 Novo Nordisk A/S GLP-1 compositions and uses thereof
US11752198B2 (en) 2017-08-24 2023-09-12 Novo Nordisk A/S GLP-1 compositions and uses thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003245160B2 (en) 2002-06-28 2009-09-24 Arbutus Biopharma Corporation Method and apparatus for producing liposomes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585179A (en) * 1966-08-05 1971-06-15 Kyowa Hakko Kogyo Kk Process for extracting proteins from microorganisms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400816D0 (en) * 1984-01-12 1984-02-15 Univ Birmingham Flocculating agent
SE8505921D0 (en) * 1985-12-13 1985-12-13 Kabigen Ab A METHOD TO EXPORT GENE PRODUCTS TO THE GROWTH MEDIUM OF GRAM NEGATIVE BACTERIA
GB8604440D0 (en) * 1986-02-22 1986-03-26 Bovril Ltd Process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3585179A (en) * 1966-08-05 1971-06-15 Kyowa Hakko Kogyo Kk Process for extracting proteins from microorganisms

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Biochimica et Biophysica ACTA, Vol. 38, issued 1960, A. GAREN and C. LEVINTHAL, a fine Structure Genetic and Chemical Study of the Enzyme Alkaline Phosphatase of E. Coli. pages 470-483. see especially page 473 last paragraph, continued on 474. *
Nucleic Acids Research, Vol. 14, Number 18, issued 1986, ABRAHAMSEN et al., Secretion of Heterologous Gene Products to the Culture Medium of E. Coli, pages 7487-7501. *
SCOPES, ROBERT K., "Protein Purification", 1982, Springer-Verlag, New York, pages 61-63. *
See also references of EP0422124A4 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0600247A3 (en) * 1992-11-05 1995-05-10 Hoechst Ag Method of selective desactivation of unwanted protein in a protein mixture, with a mircowave radiation.
EP0600247A2 (en) * 1992-11-05 1994-06-08 Hoechst Aktiengesellschaft Method of selective desactivation of unwanted protein in a protein mixture, with a mircowave radiation
US5985304A (en) * 1998-02-25 1999-11-16 Battelle Memorial Institute Barrier preventing wood pest access to wooden structures
US6596509B1 (en) 1998-07-10 2003-07-22 Cornell Research Foundation, Inc. Recombinant constructs and systems for secretion of proteins via type III secretion systems
US8846618B2 (en) 2001-06-28 2014-09-30 Novo Nordisk A/S Stable formulation of modified GLP-1
WO2004048588A1 (en) * 2002-11-26 2004-06-10 Novo Nordisk A/S Process for purifying a fermentation-derived product
US8114959B2 (en) 2003-06-03 2012-02-14 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
US8614181B2 (en) 2003-06-03 2013-12-24 Novo Nordisk A/S Stabilized pharmaceutical peptide compositions
US8114833B2 (en) 2003-11-20 2012-02-14 Novo Nordisk A/S Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices
US8710181B2 (en) 2004-08-31 2014-04-29 Novo Nordisk A/S Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
US8748376B2 (en) 2004-11-12 2014-06-10 Novo Nordisk A/S Stable formulations of peptides
WO2006101441A3 (en) * 2005-03-24 2006-12-21 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
WO2006101441A2 (en) * 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
RU2646103C2 (en) * 2016-03-30 2018-03-01 Федеральное бюджетное учреждение науки Государственный научный центр прикладной микробиологии и биотехнологии (ФБУН ГНЦ ПМБ) Method for renatured protein g isolation from marked polyacrylamide gel
US11752198B2 (en) 2017-08-24 2023-09-12 Novo Nordisk A/S GLP-1 compositions and uses thereof
US11318191B2 (en) 2020-02-18 2022-05-03 Novo Nordisk A/S GLP-1 compositions and uses thereof

Also Published As

Publication number Publication date
EP0422124A1 (en) 1991-04-17
EP0422124A4 (en) 1991-10-16
JPH03505401A (en) 1991-11-28

Similar Documents

Publication Publication Date Title
Moks et al. Large–Scale Affinity Purification of Human Insulin–Like Growth Factor I from Culture Medium of Escherichia Coli
US4355104A (en) Bacteriolytic proteins
WO1990000200A1 (en) Thermal release of recombinant protein into culture media
US4520016A (en) Bacteriolytic proteins
JP2521413B2 (en) DNA coding for human growth hormone which is directly linked to the DNA coding for the signal sequence
JP2686090B2 (en) Novel fusion protein and purification method thereof
JPH0665305B2 (en) Method for stabilizing host cell containing recombinant DNA
CA2162353A1 (en) Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease
US4652628A (en) Methods and compositions for expression of BTI endotoxin
KR950001992B1 (en) Method of producing peptides
LT3916B (en) Method for production porcine growth hormone
Koganesawa et al. Expression and purification of a small cytokine growth-blocking peptide from armyworm Pseudaletia separata by an optimized fermentation method using the methylotrophic yeast Pichia pastoris
US5043430A (en) Process for treating insoluble heterologous protein
CA2687542C (en) Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
GB2068969A (en) Gene expression
US4430428A (en) Composition of matter and process
WO1999007735A2 (en) Recombinant expression of insulin c-peptide
IE58860B1 (en) Method for recovering purified growth hormones from genetically engineered microorganisms
EP0372352B1 (en) Aequorin fused with a protein having a specific-binding activity, its preparation, its purification and detection method by its use
EP0342892B1 (en) Extraction of human interleukin-4 from bacteria
EP0659886B1 (en) Enzymatic conversion of proteins using immobilized dictyostelium dipeptidylaminopeptidase
CN1085253A (en) Dictyostelium dipeptidylaminopeptidase
RU2143492C1 (en) Recombinant plasmid encoding fused protein as precursor of human insulin (variants), strain of bacterium escherichia coli - producer of fused protein as precursor of human insulin (variants), method of human insulin preparing
US5136024A (en) Extraction of granulocyte macrophage colony stimulating factor from bacteria
RU2208637C1 (en) Method for preparing gene-engineering human insulin

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): DK FI JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1989908341

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1989908341

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1989908341

Country of ref document: EP